• Expert Opin Drug Saf · Sep 2009

    Review

    Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.

    • Robert Pirker.
    • Medical University of Vienna, Department of Medicine I, Währinger Gürtel 18-20, A-1090 Vienna, Austria. robert.pirker@meduniwien.ac.at
    • Expert Opin Drug Saf. 2009 Sep 1; 8 (5): 515-22.

    AbstractChemotherapy-induced anemia in patients with cancer can effectively be treated with erythropoiesis-stimulating agents. These drugs, which are currently indicated only in patients without curative treatment intent, increase hemoglobin (Hb) levels, reduce the risk for transfusions and improve the quality of life. Treatment should be initiated when the Hb level decreases to about 10 g/dl and the target Hb level should not exceed 12 g/dl. Hypertension and thromboembolic events are the main side effects. The association between erythropoietic proteins and clinical outcome including survival warrants further studies.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…